After a recent announcement from Novo Nordisk I cleared my schedule to record this episode with Dr. Todd Hobbs, Chief Medical Officer for North America and Ken Inchausti, Senior Director of Corporate Communications. In this open discussion they share resources and cost saving programs, details about insulin production, insulin trials and what’s on the horizon for insulin therapies. I learned SO much about a drug I’ve been taking for decades!
#85: Dr. Todd Hobbs & Ken Inchausti | An Open Conversation about Insulin with Novo Nordisk
By Amber Clour on May 4, 2020
Podcast: Play in new window | Download (132.7MB)